Dermatologia
Estudo prospectivo intervencionista | Efeitos do resfriamento do couro cabeludo na preservação capilar e no crescimento capilar em pacientes com câncer de mama sob quimioterapia.
20 Mai, 2022 | 13:20hM-A | Tratamentos imunomodulatórios sistêmicos para dermatite atópica.
13 Mai, 2022 | 12:29hComentário: Living review compares treatments for atopic dermatitis – HealthDay
Comentário no Twitter:
This systematic review and meta-analysis provides up-to-date comparative evidence of new and old systemic treatments for atopic dermatitis, like biologics and JAK inhibitors. https://t.co/ihqQWlihc7 @aaron_drucker
— JAMA Dermatology (@JAMADerm) March 16, 2022
Diretriz | Dermatite de contato.
12 Mai, 2022 | 14:34hGerman S1 guideline: Contact dermatitis – Journal of the German Society of Dermatology
Revisão | Complicações relacionadas a tatuagens no departamento de emergência.
12 Mai, 2022 | 14:32hTattoo-related Complications in the Emergency Department – emDocs
Estudo de coorte | Recorrência e risco de mortalidade do carcinoma de células de Merkell pelo estágio do câncer e tempo de diagnóstico.
6 Mai, 2022 | 17:30hRecurrence and Mortality Risk of Merkel Cell Carcinoma by Cancer Stage and Time From Diagnosis – JAMA Dermatology (link para o resumo – $ para o texto completo)
Entrevista com o autor: Recurrence and Mortality Risk of Merkel Cell Carcinoma by Cancer Stage and Time From Diagnosis
Comunicado de imprensa: Patients with rare skin cancer, Merkel cell carcinoma, face 40% recurrence rate – University of Washington School of Medicine
Comentário no Twitter
In this cohort study, Merkel cell carcinoma (MCC) recurrence rate was 40%, more than 90% of MCC recurrences arose within 3 years. https://t.co/46rDnVtyHh
— JAMA Dermatology (@JAMADerm) February 23, 2022
Estudo de coorte | Espectro do risco de câncer de pele não queratinócito entre receptores de transplante de órgão sólido.
6 Mai, 2022 | 17:09hSpectrum of Nonkeratinocyte Skin Cancer Risk Among Solid Organ Transplant Recipients in the US – JAMA Dermatology (link para o resumo – $ para o texto completo)
Entrevista com o autor: Nonkeratinocyte Skin Cancer Risk Among Solid Organ Transplant Recipients
Comentário no Twitter
This cohort study found elevated incidence for common and rare skin #cancer in solid organ #transplant recipients. Long-term immunosuppression and UV radiation are important risk factors. Treatment with mTOR inhibitors may reduce #melanoma risk. https://t.co/V6Wbbhtyeq
— JAMA Dermatology (@JAMADerm) March 9, 2022
Consenso de especialistas | Tratamento tópico da candidíase vulvovaginal recorrente.
2 Mai, 2022 | 13:50hConsenso sobre o tratamento da tinea pedis.
27 Abr, 2022 | 16:22hDiretriz | Linfomas cutâneos.
27 Abr, 2022 | 15:32hEstudo randomizado | Eficácia e segurança de longo prazo de ixekizumabe por até 108 semanas em pacientes pediátricos com psoríase moderada a grave.
19 Abr, 2022 | 12:16h
Comentário no Twitter
In this RCT, by 108 weeks of use of ixekizumab for pediatric psoriasis, PASI 75/90/100 were achieved in 92%/79%/55%, respectively, of children, with clearance of nails in 68%, scalp in 76%, genital lesions in 88%, and palm/sole involvement in 90%. https://t.co/vk73Z3MKi4
— JAMA Dermatology (@JAMADerm) April 13, 2022